AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Patent granted for nonlive FluINsure vaccine.
2004 FEB 11 - (NewsRx.com & NewsRx.net) -- ID Biomedical has received an official "Notice of Allowance" from the United States Patent and Trademark Office with respect to its patent application entitled, "Proteosome Influenza Vaccine."
This newly issued patent covers proteosome-based, nonlive, intranasal subunit vaccine compositions for the prevention of influenza virus infection. The patent also covers methods to prepare the vaccine. Patent protection in the United States for subunit Proteosome influenza vaccines extends to February 15, 2021.
The company notes that allowance of this patent further enhances the strategic development of a broad intellectual property estate surrounding patented core technology based upon vaccine formulations comprising Proteosome adjuvant/delivery technologies.
"This allowed ...
- ID Biomedical announces United States patent grant for non-live FluINsure(TM)...
- Press release article from: PR Newswire January 14, 2004 700+ words
ID Biomedical announced today that it has received an official Notice of Allowance from the United States Patent and Trademark Office with respect...development team," stated Todd R. Patrick, ID Biomedical's President and Chief Operating Officer...
- ID Biomedical announces filing of United States registration statement; TRADING...
- Press release article from: PR Newswire September 24, 2003 700+ words
ID Biomedical Corporation ("ID Biomedical") announced that it has now...registration statement with the United States Securities and Exchange Commission...5,000,000 common shares. ID Biomedical previously announced that it has...
- ID Biomedical Corporation of Quebec obtains United States patent.
- Newspaper article from: BIOTECH Patent News March 1, 2009 700+ words
ID Biomedical Corporation of Quebec (Laval, Canada) has patented an adjuvant complex composed of bacterial outer membrane protein proteosomes...
- ID Biomedical announces strategic alliances for U.S. marketing and distribution...
- Press release article from: PR Newswire December 6, 2004 700+ words
...December 6, 2004 ID Biomedical Corporation (TSX...wholesalers in the United States: Henry Schein...vaccine from ID Biomedical beginning upon United States Food & Drug...the parties that ID Biomedical's Fluviral will...
- ID Biomedical announces positive results on vaccine against bioterrorist...
- Press release article from: PR Newswire October 10, 2002 700+ words
...FirstCall/ - ID Biomedical announced today...these results, ID Biomedical and the United States Army Medical Research...institutes in the United States. These laboratories...sector. About ID Biomedical ID Biomedical is...
- ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral...
- Press release article from: PR Newswire March 30, 2005 700+ words
...On March 15, ID Biomedical announced that...advised by the United States Food and Drug...Canada and the United States. ID Biomedical produces Fluviral...Canada and in the United States. ID Biomedical is dedicated to...
- ID Biomedical to pursue U.S. accelerated approval process for its influenza...
- Press release article from: PR Newswire March 15, 2005 700+ words
...FirstCall/ -- ID Biomedical Corporation...advised by the United States Food and Drug...trial in the United States, originally...subjects. ID Biomedical believes it...and in the United States. ID Biomedical is dedicated...
- ID Biomedical receives clearance for Fluviral clinical testing in the U.S.
- Press release article from: PR Newswire January 7, 2005 700+ words
...Specialty Group and McKesson Corporation. About ID Biomedical ID Biomedical is an integrated biotechnology company dedicated...marketing from its facilities in Canada and in the United States. ID Biomedical is dedicated to becoming a premier vaccine...
Source: HighBeam Research, Patent granted for nonlive FluINsure vaccine.